Canada Pension Plan Investment Board’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-5,600
Closed -$147K – 1806
2025
Q4
$147K Buy
+5,600
New +$145K ﹤0.01% 1741
2025
Q3
– Sell
-80,400
Closed -$1.6M – 1399
2025
Q2
$1.6M Buy
+80,400
New +$1.57M ﹤0.01% 913
2024
Q4
– Sell
-3,200
Closed -$69.5K – 1441
2024
Q3
$69.5K Hold
3,200
– – ﹤0.01% 1211
2024
Q2
$62.8K Buy
+3,200
New +$66.8K ﹤0.01% 1247
2022
Q2
– Sell
-88
Closed -$6K – 1306
2022
Q1
$6K Sell
88
-2,890
-97% -$190K ﹤0.01% 1289
2021
Q4
$300K Buy
2,978
+2,363
+384% +$208K ﹤0.01% 1173
2021
Q3
$55K Buy
+615
New +$55.9K ﹤0.01% 1294

Other funds holding FLGT

Canada Pension Plan Investment Board's FLGT Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 5,600 shares — an estimated $147K sold.

Canada Pension Plan Investment Board first reported a position in FLGT in Q3 2021 and held it in 7 quarters. The position peaked at $1.6M in Q2 2025. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Canada Pension Plan Investment Board reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 5,600 Fulgent Genetics shares in Q1 2026, an estimated $147K.
  • Canada Pension Plan Investment Board first reported a position in Fulgent Genetics in Q3 2021 and held it in 7 quarters.
  • Canada Pension Plan Investment Board's Fulgent Genetics position peaked at $1.6M in Q2 2025.
  • 158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.